Trial · NCT01539226
Adverse events168
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 168
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Gynaecological chlamydia infection | Infections and infestations | Placebo Vaginal Ring | 213 | 652 | 328 |
| other | Gynaecological chlamydia infection | Infections and infestations | Dapivirine Vaginal Ring | 427 | 1,306 | 669 |
| other | Genital infection female | Infections and infestations | Placebo Vaginal Ring | 126 | 652 | 166 |
| other | Genital infection female | Infections and infestations | Dapivirine Vaginal Ring | 300 | 1,306 | 388 |
| other | Genitourinary tract gonococcal infection | Infections and infestations | Placebo Vaginal Ring | 108 | 652 | 146 |
| other | Genitourinary tract gonococcal infection | Infections and infestations | Dapivirine Vaginal Ring | 252 | 1,306 | 333 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo Vaginal Ring | 115 | 652 | 247 |
| other | Upper respiratory tract infection | Infections and infestations | Dapivirine Vaginal Ring | 231 | 1,306 | 536 |
| other | Trichomoniasis | Infections and infestations | Placebo Vaginal Ring | 103 | 652 | 150 |
| other | Trichomoniasis | Infections and infestations | Dapivirine Vaginal Ring | 225 | 1,306 | 351 |
| other | Urinary tract infection | Infections and infestations | Placebo Vaginal Ring | 100 | 652 | 151 |
| other | Urinary tract infection | Infections and infestations | Dapivirine Vaginal Ring | 185 | 1,306 | 261 |
| other | Vulvovaginal candidiasis | Infections and infestations | Placebo Vaginal Ring | 84 | 652 | 110 |
| other | Vulvovaginal candidiasis | Infections and infestations | Dapivirine Vaginal Ring | 174 | 1,306 | 258 |
| other | Vulvovaginitis | Infections and infestations | Placebo Vaginal Ring | 72 | 652 | 132 |
| other | Vulvovaginitis | Infections and infestations | Dapivirine Vaginal Ring | 115 | 1,306 | 251 |
| other | Vaginitis bacterial | Infections and infestations | Placebo Vaginal Ring | 39 | 652 | 50 |
| other | Vaginitis bacterial | Infections and infestations | Dapivirine Vaginal Ring | 99 | 1,306 | 129 |
| other | Viral rhinitis | Infections and infestations | Placebo Vaginal Ring | 35 | 652 | 64 |
| other | Viral rhinitis | Infections and infestations | Dapivirine Vaginal Ring | 73 | 1,306 | 148 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01539226/events